Related Experiment Videos

Presence and absence of the microsomal beta-glucuronidase in mice correlates with differences in the processing of

Insights

The microsomal beta-glucuronidase enzyme

Area of Science:

  • Biochemistry
  • Cell Biology
  • Enzymology

Background:

  • Beta-glucuronidase exists in both lysosomal and microsomal forms in tissues like liver and kidney.
  • The function of the microsomal beta-glucuronidase remains largely unknown.
  • Both enzyme forms are derived from the same structural gene.

Purpose of the Study:

  • To investigate the intracellular localization and processing of beta-glucuronidase.
  • To determine the relationship between microsomal beta-glucuronidase and lysosomal enzyme forms.
  • To elucidate the biosynthetic pathway of beta-glucuronidase.

Main Methods:

  • Primary mouse hepatocyte cultures were used to observe enzyme changes over time.
  • Isoelectric focusing and molecular weight analysis were performed on lysosomal beta-glucuronidase.
  • Inhibition of protease/esterase activity using phenyl-methyl-sulfonyl-fluoride and chloroquine in cultured hepatocytes.

Main Results:

  • Microsomal beta-glucuronidase decreased significantly in cultured hepatocytes within 5 days.
  • This decrease correlated with a shift in lysosomal beta-glucuronidase towards a more acidic isoelectric point (pI 5.4).
  • In vivo studies confirmed that the acidic lysosomal form (pI 5.4) is associated with the absence of microsomal beta-glucuronidase, while the less acidic form (pI 5.9) prevails when the microsomal enzyme is present.

Conclusions:

  • The study suggests a biosynthetic link between microsomal beta-glucuronidase and distinct forms of lysosomal beta-glucuronidase.
  • Interference with processing, such as using phenyl-methyl-sulfonyl-fluoride, leads to the loss of microsomal enzyme and appearance of the acidic lysosomal form.
  • Chloroquine treatment prevented the appearance of the acidic lysosomal form, indicating its role in processing.

Related Concept Videos